Design, synthesis, anticancer evaluation and docking studies of novel 2-(1-isonicotinoyl-3-phenyl-1H-pyrazol-4-yl)-3-phenylthiazolidin-4-one derivatives as Aurora-A kinase inhibitors

Peer review reports

Original Submission
30 Apr 2022	Submitted	Original manuscript
19 May 2022	Reviewed	Reviewer Report
15 Jun 2022	Reviewed	Reviewer Report
6 Jul 2022	Author responded	Author comments - Navidha Aggarwal
Resubmission - Version 2
6 Jul 2022	Submitted	Manuscript version 2
Publishing
26 Jul 2022	Editorially accepted
17 Aug 2022	Article published	10.1186/s13065-022-00852-8

Back to article page